Patent holdings for IPC class C12N 9/86

Total number of patents in this class: 163

10-year publication summary

24
18
13
13
9
10
11
16
6
6
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Theriva Biologics, Inc.
83
36
Board of Regents, The University of Texas System
5738
6
Synthetic Biologics, Inc.
31
6
Bioaster
51
6
da Volterra
36
5
BASF SE
20728
4
The Regents of the University of California
19784
4
Danisco US Inc.
1094
3
Inserm (institut National de La Sante et de La Recherche Medicale)
3358
3
Memorial Sloan-Kettering Cancer Center
1901
3
Queensland University of Technology
117
3
Tianjin University
783
3
Evonik Operations GmbH
4032
3
Evonik Degussa GmbH
1544
2
California Institute of Technology
3958
2
The Board of Trustees of the Leland Stanford Junior University
6329
2
Kaneka Corporation
4488
2
Academia Sinica
933
2
Enzymaster (Ningbo) Bio-Engineering Co., Ltd.
45
2
Ipsat Therapies Oy
2
2
Other owners 64